Wednesday, February 6, 2013

Will the record number of drug approvals in 2012, rejuvenate declining Interest in Pharma Research

The number of New drug Approvals (NME) in 2012 reached a record high of 39 after 16 years.  Discouraged by poor productivity,  same companies have been aggressively cutting their R&D spend. For most global pharma companies, R&D spend has become more or less stagnant.







Enter your email address:


Delivered by FeedBurner